People · Operator
Named in public records as an officer, director or promoter · active 2012–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Euclises Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $3.2M | $46.3M | 2012 |
John J. Talley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John J. Talley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bobby W. Sandage, Jr. | 1 | 5 |
| Robert W. Karr | 1 | 4 |
| Robert A. Beardsley | 1 | 4 |
| ROBERT J. CALCATERRA | 1 | 3 |
| Charles A. Bolten | 1 | 2 |
| Eduardo J. Martinez | 1 | 2 |
| Rick J. Ryan | 1 | 1 |
| Randy H. Weiss | 1 | 1 |
| Rajesh J. Devraj | 1 | 1 |
| Rick A. Ryan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.